Status:
UNKNOWN
Improving Physical Activity Levels in the Arabic- Speaking Residents of East Jerusalem With Prediabetes
Lead Sponsor:
Clalit Health Services
Collaborating Sponsors:
Hebrew University of Jerusalem
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
This three-arm clinical trial aims to improve levels of physical activity among Arabic- speaking residents of East Jerusalem with prediabetes. Levels of daily physical activity (assessed through activ...
Detailed Description
This is a three-arm clinical trial studying the effect of providing activity trackers with intensive motivational interview by trained physician assistants, and dietitian counselling, on the levels of...
Eligibility Criteria
Inclusion
- Pre-diabetes patients - Impaired fasting glucose at least twice between 100-125 mg/dL in the two years prior to the study; or HbA1C 5.7%-6.4% twice in the two years prior to the study; or one test of fasting glucose of 100-125 mg/dL, and one test of HbA1C between 5.7%-6.4% in the two years prior to the study.
Exclusion
- Diabetes including a doctor's diagnosis based on a medical file or a recurrence of fasting blood glucose values above 126 mg/dL in the year preceding the study or a glucose value greater than 200 mg/dL in the year prior to the study or HbA1C above 6.5%
- Treatment with diabetes drugs other than metformin, as prescribed in the medical file with regular or chronic medications
- Artificial lower limbs or inability to walk normally (eg: stroke with plegia)
- Chronic obstructive pulmonary disease
- Known heart disease (with impaired exercise tolerance)
- Pregnancy
- Medical conditions:
- a cardiac event/ Transient ischemic attack in the last year
- Cerebrovascular attack with residual impairment
- Surgery that required hospitalization in the last year
- Injury to lower limbs that prevents regular walking
- Malignancy excluding skin cancer small cell carcinoma or basal cell carcinoma
Key Trial Info
Start Date :
February 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2021
Estimated Enrollment :
375 Patients enrolled
Trial Details
Trial ID
NCT03821220
Start Date
February 15 2019
End Date
August 31 2021
Last Update
February 5 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.